Dexmedetomidine is an a2-adrenergic receptor agonist with an eight-fold greater affinity for the a2-adrenergic receptor than its sister drug clonidine. It is a sedative that is clear, colourless and tasteless and has been used in children for a number of years. Advantages of Dexmedetomidine over other agents used in paediatrics include: ease of administration; reduction in postoperative analgesic requirements; and reduction in postoperative nausea and vomiting (PONV).
Recent Posts
- SmartTots and the Power of Scientific Public–Private Partnerships with the US Food and Drug Administration
- Effects of Dexmedetomidine-Remifentanil on Neurodevelopment of Children after Inhalation Anesthesia: A Randomized Clinical Trial
- A Scoping Review of the Mechanisms Underlying Developmental Anesthetic Neurotoxicity
- Anesthesia-induced Developmental Neurotoxicity in Pediatric Population
- Experiencing Anesthesia and Surgery Early in Life Impairs Cognitive and Behavioral Development